-
EphA2 Synthetic Lethality in MYC-Driven TNBC
2026-09-15
A chemogenetic kinase-inhibitor screen identified EphA2 as a synthetic lethal vulnerability in MYC-driven triple-negative breast cancer. The study links the EphA2 inhibitor ALW-II-41-27 to MYC-selective intrinsic apoptosis, activity across p53 contexts, and tumor-growth suppression in TNBC xenografts, while also defining important limitations for translational interpretation.
-
Metal-Chelating l-Phe Nanostructures Improve ICB
2026-09-15
This Nature Nanotechnology study shows that metal-ion-chelating l-phenylalanine nanostructures can activate dendritic cells by changing potassium and calcium signaling, while short-term starvation improves nanostructure uptake and antitumor immunity. The findings provide a mechanistic strategy for remodeling immunosuppressive tumor microenvironments and increasing sensitivity to immune checkpoint blockade.
-
Naftifine HCl Workflows for Antifungal Research
2026-09-14
Build reproducible sterol-biosynthesis and fungal membrane assays with Naftifine HCl, using solvent-aware dosing, matched controls, and orthogonal readouts. The workflow also translates a muscle-regeneration study into a practical lesson: distinguish pathway-specific effects from generalized cell injury.
-
DOPE: Designing LNPs for Translational RNA Delivery
2026-09-14
A mechanistic and strategic guide to using 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) as a helper phospholipid for nucleic acid delivery, with practical validation priorities and stability lessons from recent mRNA-LNP research.
-
DOPE Workflows for Lipid and Fungal Cell Assays
2026-09-13
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is more than a helper lipid for nucleic acid delivery: it can also serve as a controlled phosphatidylethanolamine input in mechanistic studies of fungal lipid peroxidation. This guide connects formulation practice, conidial assays, rescue experiments, and troubleshooting without treating a biological rescue result as proof of a finished delivery system.
-
Novobiocin Sodium: Practical Research Workflows
2026-09-12
Novobiocin Sodium provides a time-resolved way to connect DNA replication with bacterial growth, membrane synthesis, and vacuole formation. This workflow-focused guide covers stock preparation, qPCR and microscopy readouts, recovery experiments, and troubleshooting for antibiotic resistance and pathway research.
-
Cyclo (-RGDfC) for Reliable Integrin Assays
2026-09-11
This scenario-based guide shows how Cyclo (-RGDfC) (SKU A8790) can help researchers separate αvβ3-mediated adhesion effects from true changes in cell viability. It covers solvent compatibility, assay controls, interpretation of cytotoxicity data, and practical product-selection criteria.
-
Fluorouracil: An Evolution-Aware Assay Strategy
2026-09-11
Fluorouracil and 5-Fluorouracil can reveal more than a single cytotoxicity value. This guide connects thymidylate synthase inhibition with tumor evolution, model selection, time-resolved endpoints, and heterogeneity-aware assay design.
-
PF-562271 HCl: Linking FAK Signaling to CAMLs
2026-09-10
PF-562271 HCl is a selective FAK/Pyk2 inhibitor for dissecting adhesion, migration, and tumor signaling. This article connects its experimentally useful pharmacology with circulating polyploid giant cancer macrophages, while defining what is established, what remains hypothetical, and how to design informative assays.
-
Br-DAPI Workflows for Cardiomyocyte DNA Assays
2026-09-10
Br-DAPI combines selective DNA binding with practical live-cell and fixed-cell imaging for cardiomyocyte injury models. This guide translates diabetic cardiomyopathy findings into reproducible DNA-staining workflows, assay controls, and troubleshooting decisions.
-
Angiotensin 1/2 (5-7) in Translational RAS Research
2026-09-09
A translational guide to using Angiotensin 1/2 (5-7) as a defined renin–angiotensin system reagent, connecting peptide identity, cardiovascular biology, experimental validation, and emerging SARS-CoV-2 spike–receptor research without overstating the evidence.
-
RSL3: GPX4 Inhibitor for Ferroptosis Research
2026-09-09
RSL3 is a selective glutathione peroxidase 4 inhibitor used to induce ferroptosis in cancer research. Its principal value is experimental: it links GPX4-dependent redox failure with lipid peroxidation, oncogenic RAS synthetic lethality, and cancer biology models, but it remains a preclinical research compound.
-
Batimastat (BB-94): From MMPs to NMJ Biology
2026-09-08
Batimastat (BB-94) provides a practical pharmacological lens for studying how matrix metalloproteinase activity shapes extracellular signaling. This thought-leadership perspective connects its established preclinical activity in tumor invasion and angiogenesis with emerging evidence that localized proteolytic processing of muscle-derived BDNF regulates early neuromuscular junction assembly—while clearly separating demonstrated biology from testable translational hypotheses.
-
Fluorouracil (Adrucil): Assay Reliability Guide
2026-09-08
A scenario-based guide to using Fluorouracil (Adrucil), SKU A4071, in cell viability, proliferation, and cytotoxicity assays. It connects mechanism, concentration control, storage, breast and colon cancer research, and vendor-selection decisions to reproducible laboratory workflows.
-
Early Pheromone Sensing and Neurodegeneration
2026-09-07
Peng et al. show that pheromone exposure during the L1 stage of C. elegans can reprogram neurodevelopment and accelerate neurodegeneration in adulthood. Their work identifies a circuit-level mechanism in which ascr#3 and ascr#10 are integrated through ASK, ASI, and AIA neurons, activating insulin-like signaling and suppressing neuronal autophagy.